GEHC
GE HealthCarePrevious close
63.49
Change
−0.58 / −0.91%
52-Week Range
58.75 – 89.77
P/E (TTM)
14.6
Forward P/E
13.5
Based on consensus earnings for the next 12 months
Market Cap
$28.7B
1M
−12.27%
S&P 500 −2.41% over same period
Volume / Avg Volume
3.2M / 3.1M
1.03× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-23 | $5.3B | 1.13 / 1.06 | Pending |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-29 | $5.1B | 0.99 / 1.07 | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-04 | $20.6B | 1.44 / 1.43 | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-29 | $5.1B | 1.07 / 1.07 | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-30 | $5.0B | 1.06 / — | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-30 | $4.8B | 1.23 / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 3 of its 5-year rangeCheap
5-year range 14.8 – 28.4 · Median 18.9
Last 4 quarters: $300M in buybacks + $64.0M in dividends, 1.27% of market cap combined
P/E (TTM)
14.6
P/B
2.6
P/S
1.4
Dividend Yield
0.16%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.0% on average on the first trading day after, rising 1 times
Most recent −2.27%
Volatility & Correlation
1-year beta 0.77 · Correlation with S&P 500 0.29Tracks the market
Annualized volatility 35% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q1 | 5.13 | +7.4% | — | 0.39 | 0.85 |
| FY2025 Q4 | 5.70 | +7.1% | — | 0.59 | 1.28 |
| FY2025 Q3 | 5.14 | +5.8% | — | 0.45 | 0.98 |
| FY2025 Q2 | 5.01 | +3.5% | — | 0.49 | 1.06 |
| FY2025 Q1 | 4.78 | +2.7% | — | 0.56 | 1.23 |
| FY2024 Q4 | 5.32 | +2.2% | — | 0.72 | 1.58 |
| FY2024 Q3 | 4.86 | +0.9% | — | 0.47 | 1.02 |
| FY2024 Q2 | 4.84 | +0.5% | — | 0.43 | 0.93 |
| FY2024 Q1 | 4.65 | −1.2% | — | 0.37 | 0.81 |
| FY2023 Q4 | 5.21 | +5.4% | — | 0.40 | 0.89 |
| FY2023 Q3 | 4.82 | +5.4% | — | 0.38 | 0.82 |
| FY2023 Q2 | 4.82 | +7.4% | — | 0.42 | 0.91 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| GEHC | 14.6 | +7.4% | — | −12.27% | Neutral |
| LLY | 39.9 | +47.7% | 85.8% | −3.83% | Bullish |
| JNJ | 30.6 | +6.6% | 68.2% | +1.87% | Bullish |
| ABBV | 73.7 | +10.2% | 74.7% | +4.87% | Neutral |
| MRK | 112.2 | +5.1% | 73.5% | +6.57% | Neutral |
| UNH | 23.9 | +0.4% | 88.1% | −5.15% | Neutral |
| TMO | 34.4 | +10.5% | — | +10.75% | Bullish |
| AMGN | 23.3 | +9.5% | 72.0% | −10.26% | Neutral |
| GILD | — | +10.2% | 79.8% | +6.31% | Neutral |